HBM Healthcare Investments AG

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:30:19 2025-01-17 am EST			5-day change	1st Jan Change
182.80 ^CHF	+1.56%		-3.18%	+3.86%

Jan. 05	HBM Healthcare Investments Reports Rise in FY25 Nine-month NAV	MT
Dec. 19	HBM Healthcare Investments' Sai Life Sciences Completes India IPO	MT

Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.

May 08, 2024 at 12:00 am EDT

From January 1, 2024 to March 31, 2024, the company has repurchased 43,650 shares. With this, the company has completed the repurchase of 89,360 share under the buyback announced on July 5, 2023.

Latest news about HBM Healthcare Investments AG

HBM Healthcare Investments Reports Rise in FY25 Nine-month NAV	Jan. 05	MT
HBM Healthcare Investments' Sai Life Sciences Completes India IPO	Dec. 19	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	24-10-21	CI
HBM Healthcare Investments Swings to Profit in Fiscal H1	24-10-21	MT
Swiss Stocks Advance Ahead of ECB Rate Decision	24-10-14	MT
HBM Healthcare Portfolio Company Upstream Bio Debuts on Nasdaq	24-10-14	MT
HBM Healthcare Investments Flags Return to Profit for Fiscal H1	24-10-02	MT
HBM Healthcare Investments AG Provides Earnings Guidance for the First Half of the 2024/2025	24-10-01	CI
OneSource Reportedly in Talks to Raise INR 16,700 Million in Pre-Listing Round	24-09-25	CI
HBM Healthcare Investments AG(SWX:HBMN) added to S&P Global BMI Index	24-09-22	CI
Chemomab Therapeutics to Raise $10 Million From Private Placement; Shares Fall	24-07-25	MT
HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2024	24-07-19	CI
HBM Healthcare Investments Swings to Profit in Q1	24-07-19	MT
Cartesian Therapeutics Secures $130 Million Private Placement Equity Financing	24-07-02	MT
HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal	24-05-28	MT
HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group	24-05-23	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2024	24-05-08	CI
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	24-05-08	CI
HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	24-04-03	MT
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	24-01-30	CI
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24-01-22	CI
HBM Healthcare Investments Logs Lower Fiscal Q3 Loss	24-01-22	MT
HBM Healthcare Investments Warns of FY24 Nine-month Net Loss	24-01-04	MT
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	23-11-30	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	23-11-21	MT

Chart HBM Healthcare Investments AG

Duration

Period

HBMN: Dynamic Chart

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Employees

700

Sector

Investment Management & Fund Operators

Calendar

2025-01-19 - Q3 2025 Earnings Release

More about the company